ArticleInternational journal of medical sciences2021

Granzyme family acts as a predict biomarker in cutaneous melanoma and indicates more benefit from anti-PD-1 immunotherapy.

Xia Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.